Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an
Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.
U.S. District Judge Matthew Kacsmaryk is ripping up legal procedure, the better to keep a high-profile abortion case in his hands as the new administration takes over. Last June, the Supreme Court found that the anti-abortion doctors aiming to make abortion drug mifepristone less accessible lacked standing,
A Texas judge has allowed Idaho, Kansas, and Missouri to challenge federal rules on the abortion drug mifepristone. The states want stricter regulations, citing conflict with state abortion laws. The case continues despite a prior Supreme Court decision maintaining access to the drug.
The states of Idaho, Kansas and Missouri made the request ... and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven ...
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.
An incoming new president and state legislative sessions ramping up are likely to bring more changes to abortion policy across the U.S., which is still settling after the seismic shift in 2022 when the U.
Donald Trump will become president of the USA, but what does this mean for women's rights? Trump's inauguration ceremony is due to take place today, making him the 47th president of the United States.
Since its approval in France in 1988, the abortifacient mifepristone (RU486) has proven to be a safe, effective, acceptable option for millions of women seeking abortion during the first several ...
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.
Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.